These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19479188)

  • 1. The association between high VEGF levels and multiple probable punctuate cavernous malformations.
    Abe T; Morishige M; Ooba H; Kamida T; Fujiki M; Kobayashi H; Sakoda T; Kimba Y
    Acta Neurochir (Wien); 2009 Jul; 151(7):855-9. PubMed ID: 19479188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral cavernous malformations with dynamic and progressive course: correlation study with vascular endothelial growth factor.
    Jung KH; Chu K; Jeong SW; Park HK; Bae HJ; Yoon BW
    Arch Neurol; 2003 Nov; 60(11):1613-8. PubMed ID: 14623736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
    Girard R; Zeineddine HA; Koskimäki J; Fam MD; Cao Y; Shi C; Moore T; Lightle R; Stadnik A; Chaudagar K; Polster S; Shenkar R; Duggan R; Leclerc D; Whitehead KJ; Li DY; Awad IA
    Circ Res; 2018 Jun; 122(12):1716-1721. PubMed ID: 29720384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
    Girard R; Zeineddine HA; Fam MD; Mayampurath A; Cao Y; Shi C; Shenkar R; Polster SP; Jesselson M; Duggan R; Mikati AG; Christoforidis G; Andrade J; Whitehead KJ; Li DY; Awad IA
    Transl Stroke Res; 2018 Feb; 9(1):34-43. PubMed ID: 28819935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
    Lopez-Ramirez MA; Pham A; Girard R; Wyseure T; Hale P; Yamashita A; Koskimäki J; Polster S; Saadat L; Romero IA; Esmon CT; Lagarrigue F; Awad IA; Mosnier LO; Ginsberg MH
    Blood; 2019 Jan; 133(3):193-204. PubMed ID: 30442679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical progression and familial occurrence of cerebral cavernous angiomas: the role of angiogenic and growth factors.
    Maiuri F; Cappabianca P; Gangemi M; De Caro Mdel B; Esposito F; Pettinato G; de Divitiis O; Mignogna C; Strazzullo V; de Divitiis E
    Neurosurg Focus; 2006 Jul; 21(1):e3. PubMed ID: 16859256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
    Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
    Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral cavernous malformations and epilepsy.
    Awad I; Jabbour P
    Neurosurg Focus; 2006 Jul; 21(1):e7. PubMed ID: 16859260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution and content of transforming growth factor-β1 and vascular endothelial growth factor in each layer of concentrated growth factors].
    Chen F; Pan SX; Feng HL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):860-865. PubMed ID: 27752171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Blood Prognostic Biomarker Signatures for Hemorrhagic Cerebral Cavernous Malformations (CCMs).
    Croft J; Grajeda B; Aguirre LA; Abou-Fadel JS; Ellis CC; Estevao I; Almeida IC; Zhang J
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI.
    Dammann P; Wrede KH; Maderwald S; El Hindy N; Mueller O; Chen B; Zhu Y; Hütter BO; Ladd ME; Schlamann M; Sandalcioglu IE; Sure U
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):194-200. PubMed ID: 23085932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
    Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of thrombolysis in patients with acute ischemic stroke and cerebral cavernous malformations.
    Erdur H; Scheitz JF; Tütüncü S; Fiebach JB; Endres M; Werring DJ; Nolte CH
    Stroke; 2014 Jun; 45(6):1846-8. PubMed ID: 24788970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus.
    Heep A; Stoffel-Wagner B; Bartmann P; Benseler S; Schaller C; Groneck P; Obladen M; Felderhoff-Mueser U
    Pediatr Res; 2004 Nov; 56(5):768-74. PubMed ID: 15319463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of adult cavernous malformations: a study of 56 patients.
    Sure U; Freman S; Bozinov O; Benes L; Siegel AM; Bertalanffy H
    J Neurosurg; 2005 Feb; 102(2):342-7. PubMed ID: 15739564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cavernous malformations.
    Smith ER; Scott RM
    Neurosurg Clin N Am; 2010 Jul; 21(3):483-90. PubMed ID: 20561497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
    Vural P; Degirmencioglu S; Erden S; Gelincik A
    Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of multiple Cerebral Cavernous Malformations in a patient with Neurofibromatosis type 1.
    Rerat K; Parker F; Nasser G; Vidaud D; Riant F; Tournier-Lasserve E; Denier C
    J Neurol Sci; 2015 Mar; 350(1-2):98-100. PubMed ID: 25702150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.